Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Qiming Venture Partners

Qiming Venture Partners

Institutional venture firmHong Kongqimingvc.comSEC venture capital fund adviserfundraising evidencepart of Qiming

One of 3 advisers that share qimingvc.com; the firm is Qiming. Qiming Global Management, LLC, Qiming U.S. Ventures Management, LLC. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

venture manager, reported GAV $4,925M across 15 vehicles

Importance
56
elevated
Active deployment
65
high
Emerging
0
low
Completeness
63
high
Freshness
98
high
Research priority
27
moderate
Identity and regulatory footprint
Headquarters
Hong Kong, Hong Kongadviserinfo.sec.gov
Office address
4205-06, 42/F, GLOUCHESTER TOWER, THE LANDMARK, 15 QUEENS RD, CENTRAL, Hong Kongadviserinfo.sec.gov
Business phone
852-3620-3601adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 30, 2024
Private funds reported
14 (14 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$4.9Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business phone
852-3620-3601adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
10 observed deals
Stated (the firm’s website)
Sectors
not stated or not yet read
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series a 50%series c 25%seed 13%series b 13%
Stage at first entry
series a 57%seed 14%series b 14%series c 14%
Sectors
unknown 100%
lead rate 50%follow-on rate 11%new logos, 12 months 10
Funds and vehicles
15 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Qiming Venture Partners VI, LPFund2019 adv first reportedMature$1.5B
Mar 30, 2024
74$0
of $900M
Mar 20, 2018
Qiming Managing Directors Fund VI, LPFund2019 adv first reportedMature$41.6M
Mar 30, 2024
45$0
of $24.5M
Apr 6, 2018
Qiming Venture Partners V, LPFund2016 adv first reportedHarvest$1.2B
Mar 30, 2024
63$0
of $620M
Jan 28, 2016
Qiming Managing Directors Fund V, LPFund2016 adv first reportedHarvest$38.8M
Mar 30, 2024
33$0
of $19.5M
Feb 4, 2016
Qiming Venture Partners III Annex Fund, LPContinuation vehicle2015 form d first saleHarvest$31.0M
Mar 30, 2024
20$75.0M
of $75.0M
Apr 9, 2015
Qiming Venture Partners IV, LPFund2014 adv first reportedHarvest$1.2B
Mar 30, 2024
54$0
of $480M
Mar 26, 2014
Qiming Managing Directors Fund IV, LPFund2014 adv first reportedHarvest$39.3M
Mar 30, 2024
36$0
of $25.0M
Apr 16, 2014
Qiming Venture Partners III, LPFund2011 form d first saleHarvest$582M
Mar 30, 2024
57$430M
of $460M
May 31, 2011
Qiming Managing Directors Fund III, LPFund2011 form d first saleHarvest$19.3M
Mar 30, 2024
29$13.8M
of $20.0M
Jun 17, 2011
Qiming Venture Partners II, LPFundunknownUnknown$246M
Mar 30, 2024
56unknownunknown
Qiming Venture Partners, LPFundunknownUnknown$27.4M
Mar 30, 2024
57unknownunknown
Qiming Venture Partners Ii-C, LPFundunknownUnknown$21.5M
Mar 30, 2024
2unknownunknown
Qiming Managing Directors Fund II, LPFundunknownUnknown$3.6M
Mar 30, 2024
22unknownunknown
Qiming Managing Directors Fund, LPFundunknownUnknown$310,000
Mar 30, 2024
17unknownunknown
Qiming Venture Partners IX-A, L.P.Feeder or parallelunknownFundraisingunknownunknown$0
of $600M
Nov 10, 2025
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
11 current, 5 departed
5 departed (kept with end dates)
Investments on record
10 edges, 9 companies, 1 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
浩博医药AusperBio 医疗创新Series C · Series Cparticipantunknown$120MunknownAug 27, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Enginprime MedicalSeries A · Series AleadShuo Mao (confirmed)$12.0MunknownAug 17, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Pulnovo MedicalStrategic Investmentparticipantunknown$100MunknownApr 19, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Vivatides TherapeuticsSeries A · Series Aleadunknown$54.0MunknownApr 10, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Syneron BioSeries B · Series Bparticipantunknown$150MunknownApr 3, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
ImmutrinSeries A · Series Aparticipantunknown$87.0MunknownMar 24, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
ShengShu TechnologySeries A · Series AparticipantunknownunknownunknownFeb 5, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Oricell TherapeuticsSeries C · Series Cleadunknown$70.0MunknownJan 12, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
ConvergenSeed Funding · Seedleadunknown$10.0MunknownDec 8, 2025Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
浩博医药AusperBio 医疗创新Series B2leadunknown$63.0MunknownSep 21, 2025Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
40 relationships from shared deals, counted for the whole firm
5y Capital Management Limited 2 shared · recurringBLC Advisors, Ltd. 2 shared · recurring01vc Advisor Ltd 2 shared · recurringActivant Capital Group LLC 1 shared · one timeKhosla Ventures, LLC 1 shared · one timeCollab+currency Management, LLC 1 shared · one timeBuentrip Ventures Capital Management, LLC 1 shared · one timePWV Capital Management LLC 1 shared · one timeVivo Capital, LLC 1 shared · one timeDV Partners Management 1 shared · one timeMonolith Venture Advisory Limited 1 shared · one timeB Capital Group 1 shared · one timeMomentum Capital Partners Alpha 1 shared · one timeBanyan Capital Partners Ltd. 1 shared · one time6th Man Ventures, LLC 1 shared · one timeIncubate 1 shared · one time6 Dimensions Capital 1 shared · one timeXiang He Management Services, Inc. 1 shared · one time11.2 Capital 1 shared · one timeStandard Crypto Management LP 1 shared · one timeEastlink Capital Management, LLC 1 shared · one timeHLC Vgc Management IV Limited 1 shared · one timeInnoPinnacle Fund 1 shared · one timeHanKang Capital 1 shared · one timeSherpa Capital 1 shared · one timeYuanBio Venture Capital 1 shared · one timeGaorong Ventures 1 shared · one timeOrbiMed 1 shared · one timeHSG 1 shared · one timeHighLight Capital 1 shared · one time · we led 1BioTrack Capital 1 shared · one timeTrue Light Capital 1 shared · one timeF-Prime 1 shared · one timeSR One 1 shared · one timeFrazier Life Sciences 1 shared · one time · they led 1Cambridge Enterprise Ventures 1 shared · one timeLINK-X CAPITAL 1 shared · one time · they led 1D Emerging Industry Equity Investment 1 shared · one timeBeijing Artificial Intelligence Industry Investment Fund 1 shared · one timeZhongguancun Science City 1 shared · one time · they led 1
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
22 dated events
  1. Mar 31, 2026
    Ryan Kendall Baker (Director) no longer on Schedule A of Qiming Venture Partners
  2. Mar 29, 2022
    Robert Headley (Director) no longer on Schedule A of Qiming Venture Partners
  3. Mar 1, 2021
    Ryan Kendall Baker joined Schedule A of Qiming Venture Partners as Director
  4. Mar 29, 2019
    Qiming Managing Directors Fund VI, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $23,830,000
  5. Mar 29, 2019
    Qiming Venture Partners VI, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $866,190,000
  6. Mar 31, 2016
    Qiming Venture Partners V, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $628,500,000
  7. Mar 31, 2016
    Qiming Managing Directors Fund V, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $19,500,000
  8. Mar 31, 2016
    Qiming Venture Partners III Annex Fund, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $73,933,000
  9. Jan 1, 2016
    Xubo Hu joined Schedule A of Qiming Venture Partners as Director
  10. Mar 20, 2015
    John Patrick Ferry (Chief Financial Officer (U.S.)) no longer on Schedule A of Qiming Venture Partners
  11. Jun 12, 2014
    Qiming Managing Directors Fund IV, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $15,304,000
  12. Jun 12, 2014
    Qiming Venture Partners IV, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $484,696,000
  13. Mar 26, 2014
    Hans Tung (Director) no longer on Schedule A of Qiming Venture Partners
  14. Sep 1, 2013
    Bernice Wing-Yu Leung joined Schedule A of Qiming Venture Partners as Director
  15. Mar 20, 2012
    Qiming Venture Partners Ii-C, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $50,666,000
  16. Mar 20, 2012
    Qiming Venture Partners, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $226,339,000
  17. Mar 20, 2012
    Qiming Venture Partners II, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $580,061,000
  18. Mar 20, 2012
    Qiming Managing Directors Fund II, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $8,870,000
  19. Mar 20, 2012
    Qiming Venture Partners III, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $422,678,397
  20. Mar 20, 2012
    Qiming Managing Directors Fund III, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $13,480,000
  21. Mar 20, 2012
    Qiming Managing Directors Fund, LP first reported on Form ADV by Qiming Venture Partners (Venture Capital Fund), GAV $3,539,000
  22. Mar 20, 2012
    Qiming Venture Partners first filed Form ADV (ERA, venture capital fund adviser exemption)
Classification history
  1. Sep 15, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $4,925M across 15 vehicles
  2. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $4,904M across 13 vehicles
Evidence
30 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC exemption claimedventure_capital_fund_adviserMar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-03-20Mar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-03-30Mar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Mar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone852-3620-3601Mar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersHong Kong, Hong KongMar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address4205-06, 42/F, GLOUCHESTER TOWER, THE LANDMARK, 15 QUEENS RD, CENTRAL, Hong KongMar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formCorporationMar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported14Mar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$4.9BMar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Schedule a diffsadiff-1Mar 31, 2026FactIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
Venture funds reported14Mar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://WWW.QIMINGVC.COMMar 30, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)